STOCK TITAN

Pluri Inc SEC Filings

PLUR NASDAQ

Welcome to our dedicated page for Pluri SEC filings (Ticker: PLUR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

SEC filings for a clinical-stage biotech like Pluri Inc (PLUR) can run hundreds of pages, packed with scientific jargon on 3-D cell expansion, placental-derived therapies, and cultivated-meat joint ventures. Finding how much cash is left for trials, or spotting when executives file Form 4s before a financing round, is tedious.

Stock Titan solves the problem. Our AI reads every Pluri annual report 10-K, each quarterly earnings report 10-Q filing, and every 8-K material event within minutes of hitting EDGAR. It then produces plain-English summaries, highlights clinical milestones, and flags contract-development (CDMO) revenue trends so you can understand Pluri SEC documents with AI, not a microscope. You’ll also get real-time alerts on Pluri insider trading Form 4 transactions and a dashboard that links each disclosure to the exact page where the data lives.

Whether you’re monitoring a shelf registration that funds the next immunotherapy study, tracking Pluri executive stock transactions Form 4, or comparing cytokine-release safety data across periods, the entire story sits here:

  • Pluri annual report 10-K simplified – R&D spend, GMP facility capacity, key risk factors
  • Pluri quarterly earnings report 10-Q filing – cash runway, partnership revenue
  • Pluri proxy statement executive compensation – incentive alignment for trial success
  • Pluri 8-K material events explained – collaboration announcements and FDA feedback
  • Pluri Form 4 insider transactions real-time – who’s buying before pivotal data

Get Pluri SEC filings explained simply, perform Pluri earnings report filing analysis in seconds, and evaluate dilution risk, cultivated-meat commercialization timelines, and more before the market digests the news. Complex filings, simplified.

Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Pluri (PLUR)?

The current stock price of Pluri (PLUR) is $5.68 as of August 22, 2025.

What is the market cap of Pluri (PLUR)?

The market cap of Pluri (PLUR) is approximately 39.2M.
Pluri Inc

NASDAQ:PLUR

PLUR Rankings

PLUR Stock Data

39.17M
4.45M
43.41%
19.65%
0.39%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
Israel
HAIFA